Current Report Filing (8-k)
November 09 2021 - 4:36PM
Edgar (US Regulatory)
0001824884
false
00-0000000
0001824884
2021-11-09
2021-11-09
0001824884
ADOC:ClassOrdinaryShares.0001ParValuePerShareMember
2021-11-09
2021-11-09
0001824884
ADOC:RightsExchangeableIntoOnetenthOfOneClassOrdinaryShareMember
2021-11-09
2021-11-09
0001824884
ADOC:WarrantsEachExercisableForOnehalfOfOneClassOrdinaryShareEachWholeWarrantExercisableFor11.50PerShareMember
2021-11-09
2021-11-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November
9, 2021
EDOC Acquisition
Corp.
(Exact name of registrant as specified in its charter)
Cayman Islands
|
|
001-39689
|
|
N/A
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
7612 Main Street Fishers
Suite 200
Victor, NY 14564
(Address of principal executive offices, including
zip code)
Registrant’s telephone number, including
area code: (585) 678-1198
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Securities registered pursuant
to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Class A Ordinary Shares, $.0001 par value per share
|
|
ADOC
|
|
The Nasdaq Stock Market LLC
|
Rights, exchangeable into one-tenth of one Class A Ordinary Share
|
|
ADOCR
|
|
The Nasdaq Stock Market LLC
|
Warrants, each exercisable for one-half of one Class A Ordinary Share, each whole Warrant exercisable for $11.50 per share
|
|
ADOCW
|
|
The Nasdaq Stock Market LLC
|
Item 7.01
Regulation FD Disclosure.
On November 9, 2021, EDOC Acquisition Corp.
(the “Company”) issued a press release (the “Press Release”) announcing that its sponsor, American Physicians
LLC (the “Sponsor”), has requested that the Company extend the date by which the Company has to consummate a business combination
from November 12, 2021 to February 12, 2022 (the “Extension”). The Extension is the first of up to two three-month extensions
permitted under the Company’s governing documents. In connection with such Extension, the Sponsor has notified the Company that
it intends to cause an aggregate of $900,000 to be deposited into the Company’s trust account on or before November 12, 2021.
A copy of the press release is furnished
as Exhibit 99.1 hereto. The information in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed “filed” for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange
Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
EDOC ACQUISITION CORP.
|
|
|
|
Date: November 9, 2021
|
By:
|
/s/ Kevin Chen
|
|
|
Name:
|
Kevin Chen
|
|
|
Title:
|
Chief Executive Officer
|
2
Edoc Acquisition (NASDAQ:ADOC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Edoc Acquisition (NASDAQ:ADOC)
Historical Stock Chart
From Apr 2023 to Apr 2024